Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Epithelial cell adhesion molecule is an independent prognostic marker in clear cell renal carcinoma.

Eichelberg C, Chun FK, Bedke J, Heuer R, Adam M, Moch H, Terracciano L, Hinrichs K, Dahlem R, Fisch M, Schlomm T, Sauter G, Minner S.

Int J Cancer. 2013 Jun 15;132(12):2948-55. doi: 10.1002/ijc.27970. Epub 2012 Dec 17.

2.

Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.

Zimpfer A, Maruschke M, Rehn S, Kundt G, Litzenberger A, Dammert F, Zettl H, Stephan C, Hakenberg OW, Erbersdobler A.

BJU Int. 2014 Aug;114(2):296-302. doi: 10.1111/bju.12487. Epub 2014 Jan 15.

3.

Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors.

Went P, Dirnhofer S, Salvisberg T, Amin MB, Lim SD, Diener PA, Moch H.

Am J Surg Pathol. 2005 Jan;29(1):83-8.

PMID:
15613858
4.

Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.

Seligson DB, Pantuck AJ, Liu X, Huang Y, Horvath S, Bui MH, Han KR, Correa AJ, Eeva M, Tze S, Belldegrun AS, Figlin RA.

Clin Cancer Res. 2004 Apr 15;10(8):2659-69.

5.

Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma.

Joseph RW, Kapur P, Serie DJ, Eckel-Passow JE, Parasramka M, Ho T, Cheville JC, Frenkel E, Rakheja D, Brugarolas J, Parker A.

Cancer. 2014 Apr 1;120(7):1059-67. doi: 10.1002/cncr.28521. Epub 2013 Dec 30. Erratum in: Cancer. 2014 Jun 1;120(11):1752-3.

6.

Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer.

Woopen H, Pietzner K, Richter R, Fotopoulou C, Joens T, Braicu EI, Mellstedt H, Mahner S, Lindhofer H, Darb-Esfahani S, Denkert C, Sehouli J.

J Gynecol Oncol. 2014 Jul;25(3):221-8. doi: 10.3802/jgo.2014.25.3.221. Epub 2014 Jul 3.

7.

Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.

Kroeze SG, Bijenhof AM, Bosch JL, Jans JJ.

Cancer Biomark. 2010;7(6):261-8. doi: 10.3233/CBM-2010-0195. Review.

PMID:
21694464
8.

Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.

Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V; Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project; Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation.

BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.

9.

Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma.

Eichelberg C, Minner S, Isbarn H, Burandt E, Terracciano L, Moch H, Kell A, Heuer R, Chun FK, Sauter G, Fisch M, Tennstedt P.

World J Urol. 2013 Aug;31(4):847-53. doi: 10.1007/s00345-011-0783-z. Epub 2011 Oct 19.

PMID:
22009118
10.

Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.

Shioi K, Komiya A, Hattori K, Huang Y, Sano F, Murakami T, Nakaigawa N, Kishida T, Kubota Y, Nagashima Y, Yao M.

Clin Cancer Res. 2006 Dec 15;12(24):7339-46.

11.

Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer.

Benko G, Spajić B, Krušlin B, Tomas D.

Urol Oncol. 2013 May;31(4):468-74. doi: 10.1016/j.urolonc.2011.03.007. Epub 2011 Apr 21.

PMID:
21514185
12.

Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer.

Fong D, Moser P, Kasal A, Seeber A, Gastl G, Martowicz A, Wurm M, Mian C, Obrist P, Mazzoleni G, Spizzo G.

Histopathology. 2014 Apr;64(5):683-92. doi: 10.1111/his.12307. Epub 2013 Dec 2.

PMID:
24117877
13.

Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.

Kruck S, Hennenlotter J, Vogel U, Schilling D, Gakis G, Hevler J, Kuehs U, Stenzl A, Schwentner C.

BJU Int. 2012 Feb;109(4):634-8. doi: 10.1111/j.1464-410X.2011.10392.x. Epub 2011 Jun 28.

14.

Overexpression of epithelial cell adhesion molecule protein is associated with favorable prognosis in an unselected cohort of ovarian cancer patients.

Battista MJ, Cotarelo C, Jakobi S, Steetskamp J, Makris G, Sicking I, Weyer V, Schmidt M.

J Cancer Res Clin Oncol. 2014 Jul;140(7):1097-102. doi: 10.1007/s00432-014-1672-9. Epub 2014 Apr 13.

PMID:
24728493
15.

Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma.

Khella HW, Scorilas A, Mozes R, Mirham L, Lianidou E, Krylov SN, Lee JY, Ordon M, Stewart R, Jewett MA, Yousef GM.

Am J Pathol. 2015 Mar;185(3):693-703. doi: 10.1016/j.ajpath.2014.11.017. Epub 2015 Jan 5.

PMID:
25572155
16.
17.

Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas.

Jiang Z, Lohse CM, Chu PG, Wu CL, Woda BA, Rock KL, Kwon ED.

Cancer. 2008 Jun 15;112(12):2676-82. doi: 10.1002/cncr.23484.

18.

Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.

Patriarca C, Macchi RM, Marschner AK, Mellstedt H.

Cancer Treat Rev. 2012 Feb;38(1):68-75. doi: 10.1016/j.ctrv.2011.04.002. Epub 2011 May 14. Review.

PMID:
21576002
19.

Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.

Murakami N, Mori T, Yoshimoto S, Ito Y, Kobayashi K, Ken H, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Sumi M, Itami J.

Laryngoscope. 2014 Nov;124(11):E431-6. doi: 10.1002/lary.24839. Epub 2014 Jul 14.

20.

Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.

Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS.

Am J Surg Pathol. 1997 Jun;21(6):621-35.

PMID:
9199639
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk